Stuart Blitz, Hone Health

Stuart Blitz is COO and founder of Hone Health. He comes from a long career in health tech, notably at diabetes device pioneer Agamatrix. Stuart’s been working on his aggressive social media career, but in the background he launched Hone Health in the male health online telehealth/pharmacy space in March 2020 (great timing!). It’s now…

Read More

Applied Therapeutics Drug Is Denied FDA Approval in Rare Inherited Metabolic Disease

The FDA cited deficiencies in its govorestat’s application in galactosemia, a rare metabolic disease, Applied Therapeutics said. The biotech is still on track to submit a separate application for the drug in sorbitol dehydrogenase (SORD) deficiency, another rare disease that has no FDA-approved therapies. The post Applied Therapeutics Drug Is Denied FDA Approval in Rare…

Read More